Joint Bone Spine
- Print ISSN
- Electronic ISSN
- Impact factor
- Usage rank
- Article count
- Free count
- Free percentage
- PDFs via platforms
- CSA, Rcgp, Gale, Sciencedirect from 2000, Proquest, and Ingenta
Concomitant presentation of multiple vertebral and peripheral osteonecrosis in a HIV-infected patient.
Power Doppler ultrasonographic evaluation of enthesitis in psoriatic arthritis. A multi-center study.
Management of patients who require corticosteroid therapy
Joint Bone Spine 75:0 (2008)
The INTERMED questionnaire for predicting return to work after a multidisciplinary rehabilitation program for chronic low back pain
The univariate analysis showed a significant association between the INTERMED score and return to work (P<0.001; odds ratio, 0.90; 95% confidence interval, 0.86-0.96). In the multivariate analysis, prediction was best when the INTERMED score and sick leave duration were used in combination (P=0.03;...
Biological treatments given in patients with rheumatoid arthritis or ankylosing spondylitis modify HAT/HDAC (histone acetyltransferase/histo...
Should non-steroidal anti-inflammatory drugs be used continuously in ankylosing spondylitis?
We also assessed the safety profiles of both regimens. We performed a review by searching the PubMed and Embase databases using two MeSH term combinations to compare continuous and on-demand NSAID therapy in terms of disease control, radiographic progression, and safety. The only study evaluating th...
Plasma chemerin levels in rheumatoid arthritis are correlated with disease activity rather than obesity.
A shoulder mass and the geyser phenonemon.
Mesangial immunoglobulin (Ig)A glomerulonephritis in a patient with rheumatoid arthritis treated with abatacept.
We report observations of a 47-year-old seropositive woman with rheumatoid arthritis (RA) suffering from mesangial immunoglobulin (Ig)A glomerulonephritis (GN) after initiation of abatacept, a selective T-cell co-stimulation modulator cytotoxic T-lymphocyte antigen 4 (CTLA4)-Ig. She was initially tr...
Recommendations for using TNFα antagonists and French Clinical Practice Guidelines endorsed by the French National Authority for Health.
The use of TNFα antagonists must follow specific guidelines to ensure optimal effectiveness and safety. The French Society for Rheumatology (SFR) and Task Force on Inflammatory Joint Diseases (CRI), in partnership with several French learned societies, asked the French National Authority for Health...